Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Morphine-6-glucuronide (M6G) is an active metabolite of morphine that is being developed by CeNeS Pharmaceuticals as an alternative to morphine (the most commonly used opioid) for the management of postoperative pain. M6G is currently undergoing phase III clinical trials in patients with postoperative pain.

Original languageEnglish (US)
Pages (from-to)786-799
Number of pages14
JournalCurrent Opinion in Investigational Drugs
Volume9
Issue number7
StatePublished - Jul 1 2008

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain'. Together they form a unique fingerprint.

Cite this